Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 225

1.

Intra-articular delivery of synovium-resident mesenchymal stem cells via BMP-7-loaded fibrous PLGA scaffolds for cartilage repair.

Kim HJ, Han MA, Shin JY, Jeon JH, Lee SJ, Yoon MY, Kim HJ, Choi EJ, Do SH, Yang VC, He H, Yang YI.

J Control Release. 2019 Apr 4;302:169-180. doi: 10.1016/j.jconrel.2019.04.002. [Epub ahead of print]

PMID:
30954618
2.

Tat-functionalized Ag-Fe3O4 nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery.

Liu E, Zhang M, Cui H, Gong J, Huang Y, Wang J, Cui Y, Dong W, Sun L, He H, Yang VC.

Acta Pharm Sin B. 2018 Oct;8(6):956-968. doi: 10.1016/j.apsb.2018.07.012. Epub 2018 Aug 6.

3.

MMP-2-responsive fluorescent nanoprobes for enhanced selectivity of tumor cell uptake and imaging.

Sun L, Xie S, Ji X, Zhang J, Wang D, Lee SJ, Lee H, He H, Yang VC.

Biomater Sci. 2018 Sep 25;6(10):2619-2626. doi: 10.1039/c8bm00593a.

PMID:
30109310
4.

Smart Nanoparticles Undergo Phase Transition for Enhanced Cellular Uptake and Subsequent Intracellular Drug Release in a Tumor Microenvironment.

Ye G, Jiang Y, Yang X, Hu H, Wang B, Sun L, Yang VC, Sun D, Gao W.

ACS Appl Mater Interfaces. 2018 Jan 10;10(1):278-289. doi: 10.1021/acsami.7b15978. Epub 2017 Dec 29.

PMID:
29260563
5.

Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy.

Wang H, Moon C, Shin MC, Wang Y, He H, Yang VC, Huang Y.

Nanotheranostics. 2017 Mar 3;1(1):114-130. doi: 10.7150/ntno.18292. eCollection 2017. Review.

6.

Cell-Permeable, MMP-2 Activatable, Nickel Ferrite and His-Tagged Fusion Protein Self-Assembled Fluorescent Nanoprobe for Tumor Magnetic-Targeting and Imaging.

Sun L, Xie S, Qi J, Liu E, Liu D, Liu Q, Chen S, He H, Yang VC.

ACS Appl Mater Interfaces. 2017 Nov 15;9(45):39209-39222. doi: 10.1021/acsami.7b12918. Epub 2017 Nov 1.

PMID:
29058417
7.

High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA.

Ye J, Liu E, Gong J, Wang J, Huang Y, He H, Yang VC.

Theranostics. 2017 Jun 25;7(9):2495-2508. doi: 10.7150/thno.19863. eCollection 2017.

8.

Drug depot-anchoring hydrogel: A self-assembling scaffold for localized drug release and enhanced stem cell differentiation.

Li R, Pang Z, He H, Lee S, Qin J, Wu J, Pang L, Wang J, Yang VC.

J Control Release. 2017 Sep 10;261:234-245. doi: 10.1016/j.jconrel.2017.07.008. Epub 2017 Jul 8.

PMID:
28694033
9.

Tandem-multimeric F3-gelonin fusion toxins for enhanced anti-cancer activity for prostate cancer treatment.

Shin MC, Min KA, Cheong H, Moon C, Huang Y, He H, Yang VC.

Int J Pharm. 2017 May 30;524(1-2):101-110. doi: 10.1016/j.ijpharm.2017.03.072. Epub 2017 Mar 27.

PMID:
28359823
10.

Improved Protein Toxin Delivery Based on ATTEMPTS Systems.

Chen Y, Zhang M, Min KA, Wang H, Shin MC, Li F, Yang VC, Huang Y.

Curr Drug Targets. 2018 Feb 19;19(4):380-392. doi: 10.2174/1389450118666170302094758.

11.

Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.

Gao W, Ye G, Duan X, Yang X, Yang VC.

Int J Nanomedicine. 2017 Feb 7;12:1047-1064. doi: 10.2147/IJN.S115215. eCollection 2017.

12.

Effect of intravenous plasma transfusion on granulocyte and monocyte oxidative and phagocytic activity in dairy calves with failure of passive immunity.

Yang VC, Rayburn MC, Chigerwe M.

Res Vet Sci. 2017 Dec;115:24-28. doi: 10.1016/j.rvsc.2017.01.015. Epub 2017 Jan 21.

PMID:
28131968
13.

Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.

Lin T, Zhao P, Jiang Y, Tang Y, Jin H, Pan Z, He H, Yang VC, Huang Y.

ACS Nano. 2016 Nov 22;10(11):9999-10012. Epub 2016 Nov 8.

PMID:
27934069
14.

CPP-Assisted Intracellular Drug Delivery, What Is Next?

Ye J, Liu E, Yu Z, Pei X, Chen S, Zhang P, Shin MC, Gong J, He H, Yang VC.

Int J Mol Sci. 2016 Nov 14;17(11). pii: E1892. Review.

15.

Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides.

Lin T, Liu E, He H, Shin MC, Moon C, Yang VC, Huang Y.

Acta Pharm Sin B. 2016 Jul;6(4):352-8. doi: 10.1016/j.apsb.2016.04.001. Epub 2016 May 26.

16.

Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity.

Shin MC, Min KA, Cheong H, Moon C, Huang Y, He H, Yang VC.

Pharm Res. 2016 Sep;33(9):2218-2228. doi: 10.1007/s11095-016-1959-4. Epub 2016 Jun 1.

17.

Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.

Sheng J, He H, Han L, Qin J, Chen S, Ru G, Li R, Yang P, Wang J, Yang VC.

J Control Release. 2016 Jul 10;233:181-90. doi: 10.1016/j.jconrel.2016.05.015. Epub 2016 May 10.

PMID:
27178809
18.

Construction and characterization of gelonin and saporin plasmids for toxic gene-based cancer therapy.

Min KA, He H, Yang VC, Shin MC.

Arch Pharm Res. 2016 May;39(5):677-86. doi: 10.1007/s12272-016-0739-3. Epub 2016 Mar 23.

PMID:
27008027
19.

Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.

He H, Sun L, Ye J, Liu E, Chen S, Liang Q, Shin MC, Yang VC.

J Control Release. 2016 Oct 28;240:67-76. doi: 10.1016/j.jconrel.2015.10.040. Epub 2015 Oct 26. Review.

PMID:
26514292
20.

A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging.

Wang Y, Lin T, Zhang W, Jiang Y, Jin H, He H, Yang VC, Chen Y, Huang Y.

Theranostics. 2015 Apr 6;5(8):787-95. doi: 10.7150/thno.11139. eCollection 2015.

Supplemental Content

Support Center